CD15 Primary Antibody

Item Information
Catalog #
Size
Price
Description

The product of this gene transfers fucose to N-acetyllactosamine polysaccharides to generate fucosylated carbohydrate structures. It catalyzes the synthesis of the non-sialylated antigen, Lewis x (CD15). [provided by RefSeq, Jan 2009]

Product Overview
Formulation
Purified antibody in PBS with 0.05% sodium azide
Storage
4°C; -20°C for long term storage
Product Image
ELISA
Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)
Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)
WESTERN BLOT
Figure 2: Western blot analysis using CD15 mAb against human CD15 (AA: 1-147) recombinant protein. (Expected MW is 34.7 kDa)
Figure 2: Western blot analysis using CD15 mAb against human CD15 (AA: 1-147) recombinant protein. (Expected MW is 34.7 kDa)
WESTERN BLOT
Figure 3: Western blot analysis using CD15 mAb against HEK293-6e (1) and CD15 (AA: 1-147)-hIgGFc transfected HEK293-6e (2) cell lysate.
Figure 3: Western blot analysis using CD15 mAb against HEK293-6e (1) and CD15 (AA: 1-147)-hIgGFc transfected HEK293-6e (2) cell lysate.
FLOW CYTOMETRY
Figure 4: Flow cytometric analysis of THP-1 cells using CD15 mouse mAb (green) and negative control (red).
Figure 4: Flow cytometric analysis of THP-1 cells using CD15 mouse mAb (green) and negative control (red).
FLOW CYTOMETRY
Figure 5: Flow cytometric analysis of Jurkat cells using CD15 mouse mAb (green) and negative control (red).
Figure 5: Flow cytometric analysis of Jurkat cells using CD15 mouse mAb (green) and negative control (red).
For Research Use Only. Not for use in diagnostic procedures.